These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis. Channual J; Wu JJ; Dann FJ Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518 [TBL] [Abstract][Full Text] [Related]
23. Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Buske-Kirschbaum A; Kern S; Ebrecht M; Hellhammer DH Brain Behav Immun; 2007 Jan; 21(1):92-9. PubMed ID: 16714097 [TBL] [Abstract][Full Text] [Related]
24. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha. MclInnes IB Ernst Schering Res Found Workshop; 2006; (56):29-44. PubMed ID: 16329645 [TBL] [Abstract][Full Text] [Related]
25. [Clinico-immunological correlations in psoriatic arthritis based on data from determining cellular (T- and B-lymphocytes) and humoral (IgG, IgA and IgM) immunity factors]. Nikulin NK; Starostina ZD; Komarova VD Vestn Dermatol Venerol; 1981 Sep; (9):10-4. PubMed ID: 6975543 [No Abstract] [Full Text] [Related]
26. [Modulation of the lymphocyte membrane with anti-HLA ABC in psoriasis]. Paciel J; Vignale RA; Pereira A Med Cutan Ibero Lat Am; 1984; 12(5):403-8. PubMed ID: 6396466 [TBL] [Abstract][Full Text] [Related]
27. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs. Petersen J Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810 [TBL] [Abstract][Full Text] [Related]
28. [Disorders of immune regulation in psoriasis]. Lubach D; Marghescu S; Bialasiewicz AA Fortschr Med; 1980 Sep; 98(35):1343-7. PubMed ID: 7000645 [TBL] [Abstract][Full Text] [Related]
29. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function. Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975 [TBL] [Abstract][Full Text] [Related]
30. Patients with psoriatic arthritis have an increased number of lymphocytes in the duodenal mucosa in comparison with patients with psoriasis vulgaris. Lindqvist U; Kristjánsson G; Pihl-Lundin I; Hagforsen E; Michaëlsson G J Rheumatol; 2006 May; 33(5):924-7. PubMed ID: 16541478 [TBL] [Abstract][Full Text] [Related]
31. [Analysis of lymphocyte populations in psoriatic plaques following inhibition of tumor necrosis factor alpha with etanercept]. Mahiques L; Pitarch G; Sánchez-Carazo JL; Pérez-Ferriols A; Soriano CJ; Alegre V Actas Dermosifiliogr; 2007 Oct; 98(8):539-44. PubMed ID: 17919428 [TBL] [Abstract][Full Text] [Related]
32. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis. Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169 [TBL] [Abstract][Full Text] [Related]
33. Immunological reactivity in psoriatic arthritis. Jajić Z; Jajić I; Jajić I; Lukac J; Dekaris D Acta Med Iugosl; 1991; 45(2):141-50. PubMed ID: 1887809 [TBL] [Abstract][Full Text] [Related]
35. [Monocytes/macrophages in synovial tissue in chronic polyarthritis and arthrosis--differentiating from monoclonal antibodies]. Wörth WD; Müller W; Oberholzer M Z Rheumatol; 1987; 46(3):101-11. PubMed ID: 3498275 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. Taglione E; Vatteroni ML; Martini P; Galluzzo E; Lombardini F; Delle Sedie A; Bendinelli M; Pasero G; Bencivelli W; Riente L J Rheumatol; 1999 Feb; 26(2):370-2. PubMed ID: 9972971 [TBL] [Abstract][Full Text] [Related]
37. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699 [TBL] [Abstract][Full Text] [Related]